HUP9802637A3 - Semicarbazones having central nervais system activity and pharmaceutical preparations containing same and process for preparing them - Google Patents

Semicarbazones having central nervais system activity and pharmaceutical preparations containing same and process for preparing them

Info

Publication number
HUP9802637A3
HUP9802637A3 HU9802637A HUP9802637A HUP9802637A3 HU P9802637 A3 HUP9802637 A3 HU P9802637A3 HU 9802637 A HU9802637 A HU 9802637A HU P9802637 A HUP9802637 A HU P9802637A HU P9802637 A3 HUP9802637 A3 HU P9802637A3
Authority
HU
Hungary
Prior art keywords
nervais
semicarbazones
preparing
central
pharmaceutical preparations
Prior art date
Application number
HU9802637A
Other languages
English (en)
Original Assignee
Univ Saskatchewan Saskatoon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan Saskatoon filed Critical Univ Saskatchewan Saskatoon
Publication of HUP9802637A2 publication Critical patent/HUP9802637A2/hu
Publication of HUP9802637A3 publication Critical patent/HUP9802637A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/14Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being further bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
HU9802637A 1995-06-07 1996-06-07 Semicarbazones having central nervais system activity and pharmaceutical preparations containing same and process for preparing them HUP9802637A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/475,313 US5741818A (en) 1995-06-07 1995-06-07 Semicarbazones having CNS activity and pharmaceutical preparations containing same

Publications (2)

Publication Number Publication Date
HUP9802637A2 HUP9802637A2 (hu) 1999-02-01
HUP9802637A3 true HUP9802637A3 (en) 2000-09-28

Family

ID=23887035

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802637A HUP9802637A3 (en) 1995-06-07 1996-06-07 Semicarbazones having central nervais system activity and pharmaceutical preparations containing same and process for preparing them

Country Status (24)

Country Link
US (2) US5741818A (hu)
EP (1) EP0836591B1 (hu)
JP (1) JPH11506109A (hu)
KR (1) KR19990022408A (hu)
CN (1) CN1062263C (hu)
AT (1) ATE206110T1 (hu)
AU (1) AU715897B2 (hu)
BR (1) BR9609408A (hu)
CA (1) CA2223935A1 (hu)
CZ (1) CZ387497A3 (hu)
DE (1) DE69615558T2 (hu)
DK (1) DK0836591T3 (hu)
ES (1) ES2164889T3 (hu)
FI (1) FI974447A0 (hu)
GE (1) GEP20012414B (hu)
HU (1) HUP9802637A3 (hu)
IL (1) IL122350A0 (hu)
NO (1) NO310655B1 (hu)
NZ (1) NZ309707A (hu)
PL (1) PL184048B1 (hu)
PT (1) PT836591E (hu)
RU (1) RU2174115C2 (hu)
UA (1) UA62915C2 (hu)
WO (1) WO1996040628A1 (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
ATE289295T1 (de) * 1997-04-22 2005-03-15 Euro Celtique Sa Die verwendung von durch carbozyklische und heterozyklische reste substituierte semicarbazonen und thiosemicarbazonen als natriumkanalblocker
EP1568690A1 (en) * 1997-04-22 2005-08-31 Euro-Celtique S.A. The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
CA2310664C (en) 1997-11-21 2008-03-11 Euro-Celtique S.A. Substituted 2-aminoacetamides and the use thereof
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
WO1999039712A1 (en) * 1998-02-04 1999-08-12 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
TR200102790T2 (tr) 1999-03-26 2002-06-21 Euro-Celtique S.A. Aril İkameli Pirazoller, İmidazoller, Oksazoller, Tiazoller ve Piroller Ve Bunların Kullanımı.
JP2002541215A (ja) * 1999-04-09 2002-12-03 ユーロ−セルティック エス. ア. ナトリウムチャネル遮断薬組成物およびその使用
EP1239844B1 (en) 1999-12-20 2005-06-08 Nicholas J. Kerkhof Process for producing nanometer particles by fluid bed spray-drying
US8771740B2 (en) 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
ES2398093T3 (es) * 2000-03-24 2013-03-13 Euro-Celtique S.A. Pirazoles, triazoles y tetrazoles sustituidos con arilo como bloqueantes de los canales de sodio
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
AU2002303694A1 (en) 2001-05-10 2002-11-18 Sui Xiong Cai Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2002098420A1 (en) * 2001-06-01 2002-12-12 Cytovia, Inc. 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003006426A1 (en) * 2001-07-13 2003-01-23 Axxima Pharmaceuticals Ag Aromatic guanylhydrazones as effective compounds against neurodiseases
NZ531586A (en) * 2001-09-03 2005-09-30 Newron Pharm Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
AU2003230411A1 (en) * 2002-05-16 2003-12-02 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo(2,3-h)chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
AU2003241482A1 (en) * 2002-05-16 2003-12-02 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
PT1809271E (pt) * 2004-09-10 2010-08-30 Newron Pharm Spa Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio
ES2569660T3 (es) 2007-06-08 2016-05-12 Mannkind Corporation Inhibidores de la IRE-1alfa
EP2387481B1 (en) * 2008-12-10 2018-03-14 Boston Scientific Scimed, Inc. Method of forming a joint between a titanium alloy member and a steel alloy member and medical device comprising said joint
CN104402771B (zh) * 2014-11-26 2016-09-28 玉林师范学院 对羟基苯甲醛缩氨基脲的合成及在防治植物病害中的应用
CN104974053B (zh) * 2015-06-24 2017-04-26 天津久日新材料股份有限公司 一种新的氨基酮类光引发剂及在uv‑led光固化体系的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667022A (hu)
NL129087C (hu) 1961-01-19
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
NL282761A (hu) 1961-09-11
US3251064A (en) 1962-11-13 1966-05-10 Everett M Schultz beta-aminoacylphenoxy-and beta-aminoacylphenylmercapto-derivatives of monocarboxylicacids
NL300456A (hu) 1962-11-13
BE643709A (hu) * 1963-02-12 1900-01-01
DE1288086B (hu) * 1963-12-26 1969-01-30
US3392171A (en) * 1964-03-20 1968-07-09 Upjohn Co 4-morpholino-4'-hydroxy bicyclohexyls
US3304323A (en) * 1964-03-20 1967-02-14 Upjohn Co Oxygenated dicycloalkyl sulfones
US3303214A (en) * 1964-05-13 1967-02-07 Wallace & Tiernan Inc Nitrososemicarbazides
GB1164608A (en) * 1966-08-23 1969-09-17 May & Baker Ltd Semicarbazone and Thiosemicarbazone Quaternary Salts
US3712914A (en) * 1970-05-14 1973-01-23 Stauffer Chemical Co Arylidene semicarbizides
DE2420618C2 (de) * 1974-04-27 1982-09-16 C.H. Boehringer Sohn, 6507 Ingelheim Aminoalkylanilide, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen, die diese Aminoalkylanilide enthalten
US4394514A (en) * 1981-04-30 1983-07-19 Smithkline Beckman Corporation Processes for preparing 4-substituted indoles
US5266585A (en) 1981-05-12 1993-11-30 Ciba-Geigy Corporation Arylphenyl ether derivatives, compositions containing these compounds and use thereof
FI77458C (fi) * 1981-05-12 1989-03-10 Ciba Geigy Ag Nya mikrobicida arylfenyleterderivat, foerfarande foer deras framstaellning och deras anvaendning.
US4454337A (en) * 1981-06-29 1984-06-12 Smithkline Beckman Corporation Semicarbazide intermediates for preparing 4-substituted indoles
US5665673A (en) 1988-12-29 1997-09-09 Anderson; Richard J. Potentiating herbicidal compositions
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
WO1994006758A1 (en) * 1992-09-21 1994-03-31 University Of Saskatchewan Aryl semicarbazone anticonvulsants
JPH10503171A (ja) 1994-05-17 1998-03-24 ダウエランコ N−(5−イソチアゾリル)アミド有害生物防除剤
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
JP2000500742A (ja) 1995-10-30 2000-01-25 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤

Also Published As

Publication number Publication date
BR9609408A (pt) 1999-07-27
AU715897B2 (en) 2000-02-10
FI974447A (fi) 1997-12-05
AU5993896A (en) 1996-12-30
CN1190388A (zh) 1998-08-12
PL184048B1 (pl) 2002-08-30
WO1996040628A1 (en) 1996-12-19
IL122350A0 (en) 1998-04-05
NO310655B1 (no) 2001-08-06
EP0836591A1 (en) 1998-04-22
USRE38425E1 (en) 2004-02-10
CN1062263C (zh) 2001-02-21
US5741818A (en) 1998-04-21
ES2164889T3 (es) 2002-03-01
CA2223935A1 (en) 1996-12-19
RU2174115C2 (ru) 2001-09-27
PT836591E (pt) 2002-03-28
DK0836591T3 (da) 2001-11-26
FI974447A0 (fi) 1997-12-05
KR19990022408A (ko) 1999-03-25
NO975663D0 (no) 1997-12-05
UA62915C2 (en) 2004-01-15
DE69615558D1 (de) 2001-10-31
HUP9802637A2 (hu) 1999-02-01
NZ309707A (en) 1998-11-25
ATE206110T1 (de) 2001-10-15
PL323666A1 (en) 1998-04-14
EP0836591B1 (en) 2001-09-26
NO975663L (no) 1998-02-09
CZ387497A3 (cs) 1998-07-15
JPH11506109A (ja) 1999-06-02
DE69615558T2 (de) 2002-07-11
GEP20012414B (en) 2001-04-25

Similar Documents

Publication Publication Date Title
HUP9802637A3 (en) Semicarbazones having central nervais system activity and pharmaceutical preparations containing same and process for preparing them
GR970300037T1 (en) Phenol-derivatives having pharmaceutical activity and process for preparing the same
IL139235A0 (en) Pharmaceutical preparations
HUP9903106A3 (en) 7alpha-(zeta-aminoalkyl)estratrienes, process for preparing the same, pharmaceutical preparations containing said 7alpha(zeta-aminoalkyl)estratrienes and their use for preparing medicaments
PL320856A1 (en) Aerosol drug preparations
HUT65531A (en) Process for producing pyrimidine derivatives and pharmaceutical preparations containing them
HUP9603071A2 (en) Purin-6-one derivatives and pharmaceuticals preparations containing them
ZA956915B (en) Glycinamide derivatives processes for their preparation and medicines containing them
LTIP709A (en) Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations
HU9303603D0 (en) Process for producing isoquinoline derivatives and pharmaceutical preparations containing them
PL307255A1 (en) Polysubstituted derivatives of 3-acylamine 5-phenyl-1,4-benzoazepin-2-one, method of obtaining them and pharmaceutical preparations containing such derivatives
AU2322392A (en) Method and assay system for neurotrophin activity
AU5721996A (en) Catalyst and process for preparing same
HU913430D0 (en) 2-substituted-methyl-aryl-carboxylates, medical preparations containing them and process for their production
IL122173A0 (en) 3-amidochromanylsulfonyl (thio) ureas processes for their preparation their use and pharmaceutical preparations comprising them
HUT65619A (en) Process for producing bisheterocyclic compounds and pharmaceutical preparations containing them
LTIP760A (en) Novel thienothiazine derivatives, process for preparing thereof and pharmaceutical preparations
HUT68522A (en) Antimicrobial proteins, preparations containing these proteins, and method for production of them
HUT67605A (en) 1-(4-oxo-thiazolidin-2-yliden)-thiosemicarbazide derivatives, pharmaceutical preparations containing them and process for producing them
IL117078A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
HUT65300A (en) Process for producing benzimidazole derivatives and pharmaceutical preparations containing them
HUT65405A (en) Process for producing 1-heteroarylazetidines and pyrrolidines and pharmaceutical preparations containing them
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
HUT65224A (en) Process for producing alkoxymethylsubstituted pyridonbiphenyl derivatives and pharmaceutical preparations containing them
IL119822A (en) Substituted chromanylsulfonyl (thio) ureas processes for their preparation their use in pharmaceutical preparations and pharmaceutical preparations comprising them